![In Memoriam: Berrien Moore III [1941–2024]](https://assets.science.nasa.gov/dynamicimage/assets/science/esd/earth-observer/2025/2025-in-memoriam/InMemoriam-Moore..jpg)
![In Memoriam: Jeff Dozier [1944–2024]](https://assets.science.nasa.gov/dynamicimage/assets/science/esd/earth-observer/2025/2025-in-memoriam/InMemoriam-Dozier1.jpg)
Novo looks to recoup $830M from hypertension drug partner
A judge in Singapore ordered the freezing of KBP Biosciences’ assets while Novo Nordisk pursues $830 million in damages over claims that it was deceived in a 2023 licensing deal. Judge Philip Jeyaretnam
A judge in Singapore ordered the freezing of KBP Biosciences’ assets while Novo Nordisk pursues $830 million in damages over claims that it was deceived in a 2023 licensing deal.
Judge Philip Jeyaretnam
